Understanding intertumor heterogeneity is crucial because it affects the efficacy of cancer treatments. Personalized medicine and targeted therapies often rely on specific genetic markers or mutations. Therefore, recognizing the differences between tumors can lead to more effective and tailored treatment strategies.
